Evaluating Canadians ’ Values for Drug Coverage Decision Making
Decision makers are facing growing challenges in prioritizing drugs for reimbursement because of soaring drug costs and increasing pressures on financial resources. In addition to cost and effectiveness, payers are using other values to dictate which drugs are prioritized for funding, yet there are limited data on the Canadian public ’s priorities.
Source: Value in Health - Category: International Medicine & Public Health Authors: Shirin Rizzardo, Nick Bansback, Nick Dragojlovic, Conor Douglas, Kathy H. Li, Craig Mitton, Carlo Marra, Litsa Blanis, Larry D. Lynd Tags: Preference-Based Assessments Source Type: research